Clinical Trials Logo

Clinical Trial Summary

While hypotension during general anesthesia has routinely been considered to be a tolerable abnormality with little clinical consequence, the proposed study takes the innovative approach of defining hypotensive events within the construct of a patient's own hypertensive status, fractional mean arterial blood pressure (fMAP). Because the investigators primary variable is within the control of anesthesia personnel, the study portends a potentially simple and easy to implement treatment. The introduction of neuropsychometric measures as the relevant evaluator of post-operative cognitive dysfunction is innovative, and may be more relevant to the average elderly patient than simple mortality.


Clinical Trial Description

After major non-cardiac and non-cerebral surgery, postoperative cognitive dysfunction (POCD) occurs in a significant percentage of patients. The consequences of POCD are profound. Elderly patients having POCD at 1 week have an increased risk of disability or voluntary early retirement, and patients having POCD at 3 months have increased mortality.

The effect of low arterial blood pressure, called hypotension, during surgery on the incidence of POCD is not obvious. This effect has been obscured in a number of previous studies because, it was assumed that hypotension had to persist for minutes to hours to be deleterious, when, in fact, the duration is uncertain. In addition, patient outcomes were not analyzed as a function of a history of hypertension. In this research application, the investigators focus specifically on patients with a history of hypertension because their physiology is different than patients with normal arterial blood pressure. These hypertensive patients may be unable to compensate for low arterial blood pressure by a process called cerebral autoregulation. As a result, patients with a history of hypertension may be at greater risk for decreased cerebral perfusion and cerebral ischemia secondary to decreased systemic arterial blood pressure even during surgery for procedures not thought to put the brain at risk of ischemia.

In a prior retrospective study, the investigators analyzed hemodynamic data from fifty elderly (average age >60 years) patients having simple lumbar spine surgery, which is not thought to be associated with cerebral ischemia. These patients were all examined with a battery of neuropsychometric tests before and after surgery. Patients with a history of hypertension had cognitive changes that are dependent on the lowest fractional mean arterial blood pressure (fMAP), where fMAP is mean arterial blood pressure (MAP) divided by baseline MAP. Such changes were not found in patients without a history of hypertension. This relationship did not depend on the steady state fMAP or the highest fMAP reached in either group.

To confirm and extend these results the investigators therefore propose and hypothesize that: In patients with a history of hypertension, compared to patients without this history, low fMAPs during induction predict cognitive performance after surgery.

To evaluate these hypotheses the investigators will determine the incidence of post-operative cognitive dysfunction (POCD) as a function of the fMAP in hypertensive and normotensive patients undergoing elective simple lumbar spine surgery.

If the proposed study demonstrates that acute intra-operative episodes of hypotension are deleterious to cognitive performance in patients with hypertension, and that there are demonstrable consequences in terms of QOL measures, the possibility of a direct and low cost intervention will be available that will lead directly to an efficacy trial using non-invasive measures of cerebral blood flow algorithms to prevent POCD.

The investigators plan to conduct a multicenter study in which 200 elderly patients (>60 years) are tested with a validated battery of 6 neuropsychometric tests before simple elective lumbar spine surgery (microdiscectomy or 1-2 level laminectomies without fusions lasting <5 hours and not requiring blood transfusions) and two times after surgery, at 24 hours and at 1 month. Two questionnaires for QOL will be performed before surgery and at 1 month. Patients will be questioned whether they have a history of hypertension, and, if they do, then its duration and treatment.

Our analysis will be based on comparing the fMAP to the neuropsychometric performance before and after surgery. To see if neuropsychometric changes occur as a component of a routine anesthetic, anesthesiologists will not be given a specific protocol for intraoperative management.

The primary outcome measure will be changes in test performance between baseline and the post-operative period at 1 day and 1 month. This primary measure will be a rating of overall change in performance compared to three values of fMAPs: lowest, steady state and highest fMAP attained. Our analysis will also include uni- and multi-variate analyses which will include and QOL. ;


Study Design

Observational Model: Case Control, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT01140854
Study type Observational
Source Columbia University
Contact
Status Completed
Phase N/A
Start date January 2009
Completion date December 2014

See also
  Status Clinical Trial Phase
Terminated NCT04591808 - Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia Phase 3
Recruiting NCT04515303 - Digital Intervention Participation in DASH
Completed NCT05433233 - Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension N/A
Completed NCT05491642 - A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses Phase 1
Completed NCT03093532 - A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT05529147 - The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
Recruiting NCT05976230 - Special Drug Use Surveillance of Entresto Tablets (Hypertension)
Recruiting NCT06363097 - Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
Completed NCT06008015 - A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers Phase 1
Completed NCT05387174 - Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period N/A
Completed NCT04082585 - Total Health Improvement Program Research Project
Recruiting NCT05121337 - Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension N/A
Withdrawn NCT04922424 - Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men Phase 1
Active, not recruiting NCT05062161 - Sleep Duration and Blood Pressure During Sleep N/A
Not yet recruiting NCT05038774 - Educational Intervention for Hypertension Management N/A
Completed NCT05087290 - LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
Completed NCT05621694 - Exploring Oxytocin Response to Meditative Movement N/A
Completed NCT05688917 - Green Coffee Effect on Metabolic Syndrome N/A
Recruiting NCT05575453 - OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure N/A